Export 549 results:
Author Title [ Type(Asc)] Year
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
Journal Article
M. A. Beydoun, Gamaldo, A. A., Beydoun, H. A., Shaked, D., Zonderman, A. B., and Eid, S. M., Trends, Predictors, and Outcomes of Healthcare Resources Used in Patients Hospitalized with Alzheimer's Disease with at Least One Procedure: The Nationwide Inpatient Sample., J Alzheimers Dis, vol. 57, no. 3, pp. 813-824, 2017.
R. Guerreiro, Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., Hazrati, L., Collinge, J., Pocock, J., Lashley, T., Williams, J., Lambert, J. - C., Amouyel, P., Goate, A., Rademakers, R., Morgan, K., Powell, J., St George-Hyslop, P., Singleton, A., and Hardy, J., TREM2 variants in Alzheimer's disease., N Engl J Med, vol. 368, no. 2, pp. 117-27, 2013.
L. García Barrado, Coart, E., Vanderstichele, H. M. J., and Burzykowski, T., Transferring cut-off values between assays for cerebrospinal fluid Alzheimer's disease biomarkers., J Alzheimers Dis, vol. 49, no. 1, pp. 187-99, 2016.
C. R. Jack, Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., Lesnick, T. G., Pankratz, V. S., Donohue, M. C., and Trojanowski, J. Q., Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers., Lancet Neurol, vol. 12, no. 2, pp. 207-16, 2013.
R. A. Sperling, Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., Park, D. C., Reiman, E. M., Rowe, C. C., Siemers, E., Stern, Y., Yaffe, K., Carrillo, M. C., Thies, B., Morrison-Bogorad, M., Wagster, M. V., and Phelps, C. H., Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease., Alzheimers Dement, vol. 7, no. 3, pp. 280-92, 2011.
B. Dubois, Padovani, A., Scheltens, P., Rossi, A., and Dell'Agnello, G., Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges., J Alzheimers Dis, vol. 49, no. 3, pp. 617-31, 2016.
S. Hoon Choi, Kim, Y. Hye, Hebisch, M., Sliwinski, C., Lee, S., D'Avanzo, C., Chen, H., Hooli, B., Asselin, C., Muffat, J., Klee, J. B., Zhang, C., Wainger, B. J., Peitz, M., Kovacs, D. M., Woolf, C. J., Wagner, S. L., Tanzi, R. E., and Kim, D. Yeon, A three-dimensional human neural cell culture model of Alzheimer's disease., Nature, vol. 515, no. 7526, pp. 274-8, 2014.
Y. Zhang, Wang, S., Phillips, P., Yang, J., and Yuan, T. - F., Three-Dimensional Eigenbrain for the Detection of Subjects and Brain Regions Related with Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 4, pp. 1163-79, 2016.
M. W. Granger, Franko, B., Taylor, M. W., Messier, C., St George-Hyslop, P., and Bennett, S. A. L., A TgCRND8 Mouse Model of Alzheimer's Disease Exhibits Sexual Dimorphisms in Behavioral Indices of Cognitive Reserve., J Alzheimers Dis, vol. 51, no. 3, pp. 757-73, 2016.
K. Iqbal, Liu, F., Gong, C. - X., and Grundke-Iqbal, I., Tau in Alzheimer disease and related tauopathies., Curr Alzheimer Res, vol. 7, no. 8, pp. 656-64, 2010.
C. M. Roe, Babulal, G. M., Mishra, S., Gordon, B. A., Stout, S. H., Ott, B. R., Carr, D. B., Ances, B. M., Morris, J. C., and Benzinger, T. L. S., Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 509-513, 2018.
C. Hyoung Lyoo, Cho, H., Choi, J. Yong, Hwang, M. Song, Hong, S. Kyoon, Kim, Y. Joong, Ryu, Y. Hoon, and Lee, M. Sik, Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis., J Alzheimers Dis, vol. 51, no. 3, pp. 671-5, 2016.
N. Pierrot, Lhommel, R., Quenon, L., Hanseeuw, B., Dricot, L., Sindic, C., Maloteaux, J. - M., Octavea, J. - N., and Ivanoiu, A., Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 2, pp. 271-6, 2016.
J. Lynn, Park, M., Ogunwale, C., and Acquaah-Mensah, G. K., A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 485-501, 2022.
M. Tong, Deochand, C., Didsbury, J., and de la Monte, S. M., T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 123-38, 2016.
Y. Yu, Gao, Y., Winblad, B., Tjernberg, L. O., and Schedin-Weiss, S., A Super-Resolved View of the Alzheimer's Disease-Related Amyloidogenic Pathway in Hippocampal Neurons., J Alzheimers Dis, vol. 83, no. 2, pp. 833-852, 2021.
A. Tucholka, Grau-Rivera, O., Falcon, C., Rami, L., Sánchez-Valle, R., Lladó, A., Gispert, J. Domingo, and Molinuevo, J. Luis, Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-β and Tau., J Alzheimers Dis, vol. 61, no. 4, pp. 1575-1587, 2018.
H. Braak, Thal, D. R., Ghebremedhin, E., and Del Tredici, K., Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years., J Neuropathol Exp Neurol, vol. 70, no. 11, pp. 960-9, 2011.
D. Singh Khalsa and Newberg, A. B., Spiritual Fitness: A New Dimension in Alzheimer's Disease Prevention., J Alzheimers Dis, vol. 80, no. 2, pp. 505-519, 2021.
M. A. Fernández-Blázquez, Ávila-Villanueva, M., Maestú, F., and Medina, M., Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment., J Alzheimers Dis, vol. 52, no. 1, pp. 271-81, 2016.
S. L. Allison, Fagan, A. M., Morris, J. C., and Head, D., Spatial Navigation in Preclinical Alzheimer's Disease., J Alzheimers Dis, vol. 52, no. 1, pp. 77-90, 2016.
J. - P. Morin, Cerón-Solano, G., Velázquez-Campos, G., Pacheco-López, G., Bermúdez-Rattoni, F., and Díaz-Cintra, S., Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 69-79, 2016.
S. Seddighi, Varma, V. R., An, Y., Varma, S., Beason-Held, L. L., Tanaka, T., Kitner-Triolo, M. H., Kraut, M. A., Davatzikos, C., and Thambisetty, M., SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging., J Alzheimers Dis, vol. 61, no. 1, pp. 401-414, 2018.
E. Gómez-Tortosa, Ruggiero, M., Sainz, M. José, Villarejo-Galende, A., Prieto-Jurczynska, C., Pérez, B. Venegas, Ordás, C., Agüero, P., Guerrero-López, R., and Pérez-Pérez, J., SORL1 Variants in Familial Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 4, pp. 1275-1281, 2018.
C. Wu, Ma, Y. - H., Hu, H., Zhao, B., and Tan, L., Soluble TREM2, Alzheimer's Disease Pathology, and Risk for Progression of Cerebral Small Vessel Disease: A Longitudinal Study., J Alzheimers Dis, vol. 92, no. 1, pp. 311-322, 2023.